ARDT
Ardent Health Partners, Inc.
10.90$
+1.9%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -10.0% | +0.3% | +4.2% | +3.3% | -0.9% | +2.4% | +2.5% | +2.6% | -0.7% | +0.5% | |
| – | – | -7.9% | +0.7% | +12.6% | +8.4% | -3.9% | +6.6% | +4.3% | +5.2% | -1.9% | +1.7% | |
| – | – | -14.8% | -10.3% | +68.3% | -1.1% | -11.1% | +9.2% | +12.7% | +16.4% | -14.1% | +18.8% | |
| – | – | -14.8% | -10.3% | +68.3% | -1.1% | -11.1% | +9.2% | +12.7% | +16.4% | -14.1% | +18.8% | |
| – | – | -8.0% | -0.2% | +3.3% | -0.3% | +4.5% | +5.8% | -11.2% | -5.9% | +3.4% | -1.9% | |
| – | – | +0.5% | -0.9% | +3.1% | +6.3% | +4.6% | -1.6% | +2.7% | -2.5% | +1.0% | -3.2% | |
| – | – | +0.9% | 0.0% | +0.0% | +0.0% | +2.9% | +0.1% | 0.0% | +0.2% | 0.0% | +0.0% | |
| – | – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +17.1% | -0.8% | -1.1% | -0.7% | |
| – | – | -13.5% | -0.9% | -1.0% | +0.6% | -2.5% | +1.0% | +4.2% | +2.3% | -2.3% | +0.5% | |
| – | – | -16.0% | +8.8% | -2.3% | +6.5% | -12.2% | +6.1% | +7.1% | +11.0% | -9.1% | +2.6% | |
| – | – | -72.7% | -35.6% | +13.4% | +357.1% | -68.1% | +8.9% | +0.0% | +21.2% | +60.5% | -24.1% | |
| – | – | -19.3% | -3.1% | -0.6% | +8.8% | -7.3% | -2.0% | +4.8% | +19.9% | -8.3% | +2.4% | |
| – | – | -7.7% | +0.4% | +0.2% | +0.2% | +0.4% | 0.0% | -0.3% | -1.0% | -0.3% | +0.0% | |
| – | – | +4.2% | +5.8% | +35.9% | +12.5% | +3.9% | +6.8% | -1.3% | +36.2% | +2.9% | -22.2% | |
| – | – | +17.4% | +23.4% | +11.7% | +45.4% | +11.3% | +17.9% | -4.9% | +9.8% | +7.9% | +3.1% | |
| – | +0.8% | +0.8% | -0.3% | -3.7% | -3.5% | +6.0% | +0.3% | +0.1% | +0.1% | +0.2% | +0.9% |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.